The potential role of leptin in tumor invasion and metastasis

Amitabha Ray, Margot P Cleary

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The adipocyte-released hormone-like cytokine/adipokine leptin behaves differently in obesity compared to its functions in the normal healthy state. In obese individuals, elevated leptin levels act as a pro-inflammatory adipokine and are associated with certain types of cancers. Further, a growing body of evidence suggests that higher circulating leptin concentrations and/or elevated expression of leptin receptors (Ob-R) in tumors may be poor prognostic factors. Although the underlying pathological mechanisms of leptin's association with poor prognosis are not clear, leptin can impact the tumor microenvironment in several ways. For example, leptin is associated with a number of biological components that could lead to tumor cell invasion and distant metastasis. This includes interactions with carcinoma-associated fibroblasts, tumor promoting effects of infiltrating macrophages, activation of matrix metalloproteinases, transforming growth factor-β signaling, etc. Recent studies also have shown that leptin plays a role in the epithelial-mesenchymal transition, an important phenomenon for cancer cell migration and/or metastasis. Furthermore, leptin's potentiating effects on insulin-like growth factor-I, epidermal growth factor receptor and HER2/neu have been reported. Regarding unfavorable prognosis, leptin has been shown to influence both adenocarcinomas and squamous cell carcinomas. Features of poor prognosis such as tumor invasion, lymph node involvement and distant metastasis have been recorded in several cancer types with higher levels of leptin and/or Ob-R. This review will describe the current scenario in a precise manner. In general, obesity indicates poor prognosis in cancer patients.

Original languageEnglish (US)
Pages (from-to)80-97
Number of pages18
JournalCytokine and Growth Factor Reviews
Volume38
DOIs
StatePublished - Dec 1 2017

Fingerprint

Leptin
Tumors
Neoplasm Metastasis
Neoplasms
Adipokines
Obesity
Cells
Leptin Receptors
Epithelial-Mesenchymal Transition
Tumor Microenvironment
Macrophage Activation
Macrophages
Transforming Growth Factors
Fibroblasts
Matrix Metalloproteinases
Insulin-Like Growth Factor I
Epidermal Growth Factor Receptor
Adipocytes
Cell Movement
Squamous Cell Carcinoma

Keywords

  • Invasive cancer
  • Leptin
  • Metastasis
  • Obesity
  • Prognosis

Cite this

The potential role of leptin in tumor invasion and metastasis. / Ray, Amitabha; Cleary, Margot P.

In: Cytokine and Growth Factor Reviews, Vol. 38, 01.12.2017, p. 80-97.

Research output: Contribution to journalReview article

Ray, Amitabha ; Cleary, Margot P. / The potential role of leptin in tumor invasion and metastasis. In: Cytokine and Growth Factor Reviews. 2017 ; Vol. 38. pp. 80-97.
@article{ec415d67a9494b23b793b86040a319f9,
title = "The potential role of leptin in tumor invasion and metastasis",
abstract = "The adipocyte-released hormone-like cytokine/adipokine leptin behaves differently in obesity compared to its functions in the normal healthy state. In obese individuals, elevated leptin levels act as a pro-inflammatory adipokine and are associated with certain types of cancers. Further, a growing body of evidence suggests that higher circulating leptin concentrations and/or elevated expression of leptin receptors (Ob-R) in tumors may be poor prognostic factors. Although the underlying pathological mechanisms of leptin's association with poor prognosis are not clear, leptin can impact the tumor microenvironment in several ways. For example, leptin is associated with a number of biological components that could lead to tumor cell invasion and distant metastasis. This includes interactions with carcinoma-associated fibroblasts, tumor promoting effects of infiltrating macrophages, activation of matrix metalloproteinases, transforming growth factor-β signaling, etc. Recent studies also have shown that leptin plays a role in the epithelial-mesenchymal transition, an important phenomenon for cancer cell migration and/or metastasis. Furthermore, leptin's potentiating effects on insulin-like growth factor-I, epidermal growth factor receptor and HER2/neu have been reported. Regarding unfavorable prognosis, leptin has been shown to influence both adenocarcinomas and squamous cell carcinomas. Features of poor prognosis such as tumor invasion, lymph node involvement and distant metastasis have been recorded in several cancer types with higher levels of leptin and/or Ob-R. This review will describe the current scenario in a precise manner. In general, obesity indicates poor prognosis in cancer patients.",
keywords = "Invasive cancer, Leptin, Metastasis, Obesity, Prognosis",
author = "Amitabha Ray and Cleary, {Margot P}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.cytogfr.2017.11.002",
language = "English (US)",
volume = "38",
pages = "80--97",
journal = "Cytokine and Growth Factor Reviews",
issn = "1359-6101",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The potential role of leptin in tumor invasion and metastasis

AU - Ray, Amitabha

AU - Cleary, Margot P

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The adipocyte-released hormone-like cytokine/adipokine leptin behaves differently in obesity compared to its functions in the normal healthy state. In obese individuals, elevated leptin levels act as a pro-inflammatory adipokine and are associated with certain types of cancers. Further, a growing body of evidence suggests that higher circulating leptin concentrations and/or elevated expression of leptin receptors (Ob-R) in tumors may be poor prognostic factors. Although the underlying pathological mechanisms of leptin's association with poor prognosis are not clear, leptin can impact the tumor microenvironment in several ways. For example, leptin is associated with a number of biological components that could lead to tumor cell invasion and distant metastasis. This includes interactions with carcinoma-associated fibroblasts, tumor promoting effects of infiltrating macrophages, activation of matrix metalloproteinases, transforming growth factor-β signaling, etc. Recent studies also have shown that leptin plays a role in the epithelial-mesenchymal transition, an important phenomenon for cancer cell migration and/or metastasis. Furthermore, leptin's potentiating effects on insulin-like growth factor-I, epidermal growth factor receptor and HER2/neu have been reported. Regarding unfavorable prognosis, leptin has been shown to influence both adenocarcinomas and squamous cell carcinomas. Features of poor prognosis such as tumor invasion, lymph node involvement and distant metastasis have been recorded in several cancer types with higher levels of leptin and/or Ob-R. This review will describe the current scenario in a precise manner. In general, obesity indicates poor prognosis in cancer patients.

AB - The adipocyte-released hormone-like cytokine/adipokine leptin behaves differently in obesity compared to its functions in the normal healthy state. In obese individuals, elevated leptin levels act as a pro-inflammatory adipokine and are associated with certain types of cancers. Further, a growing body of evidence suggests that higher circulating leptin concentrations and/or elevated expression of leptin receptors (Ob-R) in tumors may be poor prognostic factors. Although the underlying pathological mechanisms of leptin's association with poor prognosis are not clear, leptin can impact the tumor microenvironment in several ways. For example, leptin is associated with a number of biological components that could lead to tumor cell invasion and distant metastasis. This includes interactions with carcinoma-associated fibroblasts, tumor promoting effects of infiltrating macrophages, activation of matrix metalloproteinases, transforming growth factor-β signaling, etc. Recent studies also have shown that leptin plays a role in the epithelial-mesenchymal transition, an important phenomenon for cancer cell migration and/or metastasis. Furthermore, leptin's potentiating effects on insulin-like growth factor-I, epidermal growth factor receptor and HER2/neu have been reported. Regarding unfavorable prognosis, leptin has been shown to influence both adenocarcinomas and squamous cell carcinomas. Features of poor prognosis such as tumor invasion, lymph node involvement and distant metastasis have been recorded in several cancer types with higher levels of leptin and/or Ob-R. This review will describe the current scenario in a precise manner. In general, obesity indicates poor prognosis in cancer patients.

KW - Invasive cancer

KW - Leptin

KW - Metastasis

KW - Obesity

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85034594478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034594478&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2017.11.002

DO - 10.1016/j.cytogfr.2017.11.002

M3 - Review article

VL - 38

SP - 80

EP - 97

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

ER -